Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-02

FDA Approved: FLAREX — Supplemental Application (Eyevance Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for FLAREX (fluorometholone acetate) submitted by Eyevance Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLAREX (Fluorometholone acetate)

Snippet

SUPPL AP for FLAREX (FLUOROMETHOLONE ACETATE)